BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30146765)

  • 1. hiPSC-derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver.
    Kiamehr M; Alexanova A; Viiri LE; Heiskanen L; Vihervaara T; Kauhanen D; Ekroos K; Laaksonen R; Käkelä R; Aalto-Setälä K
    J Cell Physiol; 2019 Apr; 234(4):3744-3761. PubMed ID: 30146765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.
    Kiamehr M; Viiri LE; Vihervaara T; Koistinen KM; Hilvo M; Ekroos K; Käkelä R; Aalto-Setälä K
    Dis Model Mech; 2017 Sep; 10(9):1141-1153. PubMed ID: 28733363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of differentially expressed genes among human hair follicle-derived iPSCs, induced hepatocyte-like cells, and primary hepatocytes.
    Xu Z; He X; Shi X; Xia Y; Liu X; Wu H; Li P; Zhang H; Yin W; Du X; Li L; Li Y
    Stem Cell Res Ther; 2018 Aug; 9(1):211. PubMed ID: 30092828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice.
    Yuan L; Zhang Y; Liu X; Chen Y; Zhang L; Cao J; Li X; Wang M; Wu K; Zhang J; Liu G; Tang Q; Yuan Q; Cheng T; Xia N
    Theranostics; 2019; 9(7):2115-2128. PubMed ID: 31037160
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocyte-like cells derived from human induced pluripotent stem cells using small molecules: implications of a transcriptomic study.
    Gao X; Li R; Cahan P; Zhao Y; Yourick JJ; Sprando RL
    Stem Cell Res Ther; 2020 Sep; 11(1):393. PubMed ID: 32917265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles.
    Kiamehr M; Heiskanen L; Laufer T; Düsterloh A; Kahraman M; Käkelä R; Laaksonen R; Aalto-Setälä K
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver biopsy derived induced pluripotent stem cells provide unlimited supply for the generation of hepatocyte-like cells.
    Calabrese D; Roma G; Bergling S; Carbone W; Mele V; Nuciforo S; Fofana I; Campana B; Szkolnicka D; Hay DC; Tchorz J; Bouwmeester T; Wieland S; Heim MH
    PLoS One; 2019; 14(8):e0221762. PubMed ID: 31465481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic transcriptome-based comparison of cellular adaptive stress response activation networks in hepatic stem cell-derived progeny and primary human hepatocytes.
    Ter Braak B; Niemeijer M; Boon R; Parmentier C; Baze A; Richert L; Huppelschoten S; Wink S; Verfaillie C; van de Water B
    Toxicol In Vitro; 2021 Jun; 73():105107. PubMed ID: 33545341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic profiling during the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
    Jellali R; Lereau Bernier M; Tauran Y; Gilard F; Danoy M; Kido T; Miyajima A; Sakai Y; Leclerc E
    Differentiation; 2020; 112():17-26. PubMed ID: 31869687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
    Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
    J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.
    Yu Y; Liu H; Ikeda Y; Amiot BP; Rinaldo P; Duncan SA; Nyberg SL
    Stem Cell Res; 2012 Nov; 9(3):196-207. PubMed ID: 22885101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells.
    Heslop JA; Kia R; Pridgeon CS; Sison-Young RL; Liloglou T; Elmasry M; Fenwick SW; Mills JS; Kitteringham NR; Goldring CE; Park BK
    Stem Cells Transl Med; 2017 May; 6(5):1321-1331. PubMed ID: 28456008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.
    Sa-Ngiamsuntorn K; Wongkajornsilp A; Phanthong P; Borwornpinyo S; Kitiyanant N; Chantratita W; Hongeng S
    Virol J; 2016 Apr; 13():59. PubMed ID: 27044429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an FXR-modulated liver-intestine hybrid state in iPSC-derived hepatocyte-like cells.
    Nell P; Kattler K; Feuerborn D; Hellwig B; Rieck A; Salhab A; Lepikhov K; Gasparoni G; Thomitzek A; Belgasmi K; Blüthgen N; Morkel M; Küppers-Munther B; Godoy P; Hay DC; Cadenas C; Marchan R; Vartak N; Edlund K; Rahnenführer J; Walter J; Hengstler JG
    J Hepatol; 2022 Nov; 77(5):1386-1398. PubMed ID: 35863491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid levels determine metabolism and CYP450 function of hepatocytes and hepatoma cell lines.
    Boon R; Kumar M; Tricot T; Elia I; Ordovas L; Jacobs F; One J; De Smedt J; Eelen G; Bird M; Roelandt P; Doglioni G; Vriens K; Rossi M; Vazquez MA; Vanwelden T; Chesnais F; El Taghdouini A; Najimi M; Sokal E; Cassiman D; Snoeys J; Monshouwer M; Hu WS; Lange C; Carmeliet P; Fendt SM; Verfaillie CM
    Nat Commun; 2020 Mar; 11(1):1393. PubMed ID: 32170132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive transcriptomic comparison of hepatocyte model systems improves selection of models for experimental use.
    Ardisasmita AI; Schene IF; Joore IP; Kok G; Hendriks D; Artegiani B; Mokry M; Nieuwenhuis EES; Fuchs SA
    Commun Biol; 2022 Oct; 5(1):1094. PubMed ID: 36241695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling of Hepatic Drug Metabolism and Responses in CYP2C19 Poor Metabolizer Using Genetically Manipulated Human iPS cells.
    Deguchi S; Yamashita T; Igai K; Harada K; Toba Y; Hirata K; Takayama K; Mizuguchi H
    Drug Metab Dispos; 2019 Jun; 47(6):632-638. PubMed ID: 30962288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.
    Asgari S; Moslem M; Bagheri-Lankarani K; Pournasr B; Miryounesi M; Baharvand H
    Stem Cell Rev Rep; 2013 Aug; 9(4):493-504. PubMed ID: 22076752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
    Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
    Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.